Oxford Immunotec Global PLC revised preliminary revenue for the fourth quarter and full year 2017. For the fourth quarter of 2017, the company expects revenue will be between $24.9 million and $25.4 million. The company's previously communicated revenue outlook was between $25.4 million and $26.4 million for the fourth quarter of 2017 For the full year 2017, the company expects revenue of between $103.0 million and $103.5 million. These preliminary results are subject to completion of the company's audit and other financial and accounting procedures. The company's previously communicated revenue outlook was between $103.5 million and $104.5 million for the full year 2017.